$935 | SAVE $165 | Single User
$1360 | SAVE $240 | Site License
$1360 | SAVE $240 | Global License

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022
[Lowest Price Guaranteed: $935]

Published by DPI Research: 01 Jul 2017 | 97530 | In Stock
Related Topics: Diabetes , Lilly

Introduction

Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices.

China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022.

The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints

1. Overall Diabetes Population (2011 – 2022)

2. Insulin Users (2011 – 2022)

3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)

4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows:

1. United States

2. United Kingdom

3. France

4. Italy

5. Spain

6. Germany

7. Japan

8. China

9. India

10. Brazil

Key Companies Covered in the Report are as follows:

1. Novo Nordisk

2. Eli Lilly

3. Sanofi

4. Owen Mumford

5. Ypsomed

6. Biocon Ltd.

Table of Contents
for Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

  • Table of Contents

    1. Executive Summary

    2. Reusable (Cartridge) Insulin Pen Market Environment & Trend (2011 – 2022)

    2.1 Reusable (Cartridge) Insulin Pen Users

    2.2 Reusable (Cartridge) Insulin Pen Market

    3. Reusable (Cartridge) Insulin Pen Market Share Analysis (2011 - 2022)

    3.1 Reusable (Cartridge) Insulin Pen Users Share

    3.2 Reusable (Cartridge) Insulin Pen Market Share

    4. Reusable (Cartridge) Insulin Pen Market Drivers and Barriers

    4.1 Market Drivers

    4.2 Market Barriers

    5. Reusable (Cartridge) Insulin Pen Market in Top Ten Countries – Geographical Landscape

    5.1 United States

    5.1.1 Overall Diabetes Population

    5.1.2 Insulin Users

    5.1.3 Reusable (Cartridge) Insulin Pen Users

    5.1.4 Reusable (Cartridge) Insulin Pen Market

    5.2 Germany

    5.2.1 Overall Diabetes Population

    5.2.2 Insulin Users

    5.2.3 Reusable (Cartridge) Insulin Pen Users

    5.2.4 Reusable (Cartridge) Insulin Pen Market

    5.3 France

    5.3.1 Overall Diabetes Population

    5.3.2 Insulin Users

    5.3.3 Reusable (Cartridge) Insulin Pen Users

    5.3.4 Reusable (Cartridge) Insulin Pen Market

    5.4 Italy

    5.4.1 Overall Diabetes Population

    5.4.2 Insulin Users

    5.4.3 Reusable (Cartridge) Insulin Pen Users

    5.4.4 Reusable (Cartridge) Insulin Pen Market

    5.5 Spain

    5.5.1 Overall Diabetes Population

    5.5.2 Insulin Users

    5.5.3 Reusable (Cartridge) Insulin Pen Users

    5.5.4 Reusable (Cartridge) Insulin Pen Market

    5.6 United Kingdom

    5.6.1 Overall Diabetes Population

    5.6.2 Insulin Users

    5.6.3 Reusable (Cartridge) Insulin Pen Users

    5.6.4 Reusable (Cartridge) Insulin Pen Market

    5.7 Japan

    5.7.1 Overall Diabetes Population

    5.7.2 Insulin Users

    5.7.3 Reusable (Cartridge) Insulin Pen Users

    5.7.4 Reusable (Cartridge) Insulin Pen Market

    5.8 China

    5.8.1 Overall Diabetes Population

    5.8.2 Insulin Users

    5.8.3 Reusable (Cartridge) Insulin Pen Users

    5.8.4 Reusable (Cartridge) Insulin Pen Market

    5.9 India

    5.9.1 Overall Diabetes Population

    5.9.2 Insulin Users

    5.9.3 Reusable (Cartridge) Insulin Pen Users

    5.9.4 Reusable (Cartridge) Insulin Pen Market

    5.10 Brazil

    5.10.1 Overall Diabetes Population

    5.10.2 Insulin Users

    5.10.3 Reusable (Cartridge) Insulin Pen Users

    5.10.4 Reusable (Cartridge) Insulin Pen Market

    6. Key Companies Analysis

    6.1 Novo Nordisk

    6.1.1 Business Overview

    6.1.2 Reusable Insulin Pen – Products Portfolio

    6.1.3 Insulin Pen – Latest Development & Trends

    6.2 Eli Lilly

    6.2.1 Business Overview

    6.2.2 Insulin Pen – Products Portfolio

    6.2.3 Insulin Pen – Latest Development & Trends

    6.3 Sanofi

    6.3.1 Business Overview

    6.3.2 Insulin Pen – Products Portfolio

    6.4 Owen Mumford

    6.4.1 Business Overview

    6.4.2 Insulin Pen – Products Portfolio

    6.5 Ypsomed

    6.5.1 Business Overview

    6.5.2 Insulin Pen – Products Portfolio

    6.5.3 Insulin Pen – Latest Development & Trends

    6.6 Biocon Ltd.

    6.6.1 Business Overview

    6.6.2 Insulin Pen – Products Portfolio

List Of Tables
in Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

List of Tables:


Table 3 1: 10 Countries – Reusable Insulin Pen Users Share (Percent), 2011 – 2016

Table 3 2: 10 Countries – Forecast for Reusable Insulin Pen Users Share (Percent), 2017 – 2022

Table 3 3: 10 Countries – Reusable Insulin Pen Market Share (Percent), 2011 – 2016

Table 3 4: 10 Countries – Forecast for Reusable Insulin Pen Market Share (Percent), 2017 – 2022

Table 4 2: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040

List Of Figures, Charts and Diagrams
in Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

List of Figures


Figure 2 1: 10 Countries – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 2 2: 10 Countries – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 2 3: 10 Countries – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 2 4: 10 Countries – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 3: United States – Insulin Users(Thousand),2011 – 2016

Figure 5 4: United States – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 5: United States – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 6: United States – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 7: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 8: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 9: Germany – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 10: Germany – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 11: Germany – Insulin Users(Thousand),2011 – 2016

Figure 5 12: Germany – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 13: Germany – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 14: Germany – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 15: Germany – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 16: Germany – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 17: France – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 18: France – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 19: France – Insulin Users(Thousand),2011 – 2016

Figure 5 20: France – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 21: France – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 22: France – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 23: France – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 24: France – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 25: Italy – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 26: Italy – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 27: Italy – Insulin Users(Thousand),2011 – 2016

Figure 5 28: Italy – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 29: Italy – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 30: Italy – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 31: Italy – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 32: Italy – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 33: Spain – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 34: Spain – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 35: Spain – Insulin Users(Thousand),2011 – 2016

Figure 5 36: Spain – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 37: Spain – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 38: Spain – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 39: Spain – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 40: Spain – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 41: United Kingdom – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 42: United Kingdom – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 43: United Kingdom – Insulin Users(Thousand),2011 – 2016

Figure 5 44: United Kingdom – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 45: United Kingdom – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 46: United Kingdom – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 47: United Kingdom – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 48: United Kingdom – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 49: Japan – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 50: Japan – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 51: Japan – Insulin Users(Thousand),2011 – 2016

Figure 5 52: Japan – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 53: Japan – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 54: Japan – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 55: Japan – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 56: Japan – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 57: China – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 58: China – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 59: China – Insulin Users(Thousand),2011 – 2016

Figure 5 60: China – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 61: China – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 62: China – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 63: China – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 64: China – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 65: India – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 66: India – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 67: India – Insulin Users(Thousand),2011 – 2016

Figure 5 68: India – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 69: India – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 70: India – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 71: India – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 72: India – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Figure 5 73: Brazil – Overall Diabetes Population (Thousand), 2011 – 2016

Figure 5 74: Brazil – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022

Figure 5 75: Brazil – Insulin Users(Thousand),2011 – 2016

Figure 5 76: Brazil – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 5 77: Brazil – Reusable Insulin Pen Users (Thousand), 2011 – 2016

Figure 5 78: Brazil – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022

Figure 5 79: Brazil – Reusable Insulin Pen Market (Million US$), 2011 – 2016

Figure 5 80: Brazil – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022

Additional Details

Publisher

DPI Research

Publisher Information

We at DPI Research strongly believe that business should be based on thorough research base. All the business or individual decisions should be based upon a well formulated strategy based on intensive research.



DPI Research  is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.



DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.



DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insights for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Reference

97530 |

Number of Pages

112

Report Format

PDF

DPI Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US)
IntroductionWhat environmental market barriers are influencing the Type 2 Diabetes (T2DM) market? F...
20 Apr 2015 by FirstWord Pharma USD $4,246 (normally
USD $4,995)
More Info
SAVE 15% today! FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5)
IntroductionWhat market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to a...
20 Apr 2015 by FirstWord Pharma USD $4,246 (normally
USD $4,995)
More Info
SAVE 15% today! Physician Views: How do endocrinologists value diabetes-focused medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
08 Dec 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: US formulary management in diabetes – are endocrinologists impressed?
Scope Pricing pressure exerted by US pharmacy benefit managers (PBMs) and managed care organisations...
12 Aug 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Five key diabetes market questions ahead of ADA 2014
Scope This year's annual meeting of the American Diabetes Association (ADA) – which will take place ...
13 Jun 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Diabetes -- KOL Insight and Consensus Outlook Modules
IntroductionThe medium term: battle lines are drawnThe fundamental drivers of the global diabetes ma...
01 May 2014 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?
ScopeThe importance of marketing is increasingly coming to the fore as diabetes-focused companies ba...
01 Aug 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Post ADA view on key diabetes market developments
ScopeLast week’s American Diabetes Association (ADA) meeting provided further evidence that the diab...
01 Jul 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? – both rejected by the FDA
ScopeEuropean-based endocrinologists are currently getting to grips with two new products that have ...
01 Jul 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by DPI Research

We at DPI Research strongly believe that business should be based on thorough research base. All the business or individual decisions should be based upon a well formulated strategy based on intensive research.

DPI Research  is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a business solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insights for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Download Free Report Summary PDF

Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...